A NOVEL MGB PROBE-BASED ASSESSMENT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CARRYING NPM1 (NUCLEOPHOSMIN) EXON 12 MUTATIONS

被引：0
|
作者：
Dvorakova, D. [1 ]
Ohlidalova, D. [1 ]
Pospisilova, J. [1 ]
Lengerova, M. [1 ]
Mayer, J. [1 ]
机构：
[1] Univ Hosp Brno, Brno, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0560
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [41] DISSECTING THE CLINICAL HETEROGENEITY OF NUCLEOPHOSMIN-1 (NPM1) MUTATED ADULT ACUTE MYELOID LEUKEMIA: THE CONTRIBUTION OF FLOW-CYTOMETRIC DETERMINATION OF MINIMAL RESIDUAL DISEASE
    Buccisano, F.
    Maurillo, L.
    Del Principe, M. I.
    Di Veroli, A.
    De Bellis, E.
    Cicconi, L.
    Divona, M.
    Ottone, T.
    Lavorgna, S.
    Rossi, V.
    Zizzari, A.
    Consalvo, M. A. Irno
    Fraboni, D.
    Conti, C.
    Del Poeta, G.
    Voso, M. T.
    Arcese, W.
    Lo Coco, F.
    Venditti, A.
    HAEMATOLOGICA, 2017, 102 : 373 - 373
  • [42] Establishment of a quenching probe method for detection of NPM1 mutations in acute myeloid leukemia cells
    Kawaguchi-Ihara, Noriko
    Itoh, Mai
    Murohashi, Ikuo
    Tohda, Shuji
    ONCOLOGY LETTERS, 2016, 11 (04) : 2429 - 2432
  • [43] Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene
    Jeziskova, Ivana
    Razga, Filip
    Toskova, Martina
    Dvorakova, Dana
    Timilsina, Shira
    Mayer, Jiri
    Racil, Zdenek
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 867 - 870
  • [44] c-MYC stain as a potential minimal residual disease marker for acute myeloid leukemia with NPM1 mutation
    Lyapichev, Kirill A.
    Behdad, Amir
    BLOOD, 2025, 145 (05) : 547 - 547
  • [45] Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection
    Zhou, Yi
    Wu, David
    Chen, Xueyan
    Fromm, Jonathan R.
    Wood, Brent L.
    MODERN PATHOLOGY, 2016, 29 : 387A - 388A
  • [46] Evaluation of NPM1 Drop Off Droplet Digital PCR Assay for Minimal Residual Disease Detection in Acute Myeloid Leukemia Patients
    Mehrotra, M.
    Guan, M.
    Manning, C.
    Dupuy, A.
    Barbari, S.
    Houldsworth, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S158 - S158
  • [47] Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection
    Zhou, Yi
    Wu, David
    Chen, Xueyan
    Fromm, Jonathan R.
    Wood, Brent L.
    LABORATORY INVESTIGATION, 2016, 96 : 387A - 388A
  • [48] DETECTION OF NPM1 AND FLT3 MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Zaker, F.
    Pazhakh, V.
    Alimoghadam, K.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S48 - S48
  • [49] Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutations
    Dvorakova, Dana
    Racil, Zdenek
    Borsky, Marek
    Robesova, Blanka
    Jeziskova, Ivana
    Razga, Filip
    Lengerova, Martina
    Mayer, Jiri
    LEUKEMIA & LYMPHOMA, 2013, 54 (05) : 1056 - 1060
  • [50] CYTOPLASMIC NPM1 DETECTION BY FLOW CYTOMETRY AS SURROGATE FOR THE PRESENCE OF MUTATIONS IN THE NPM1 GENE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Oelschlaegel, U.
    Koch, S.
    Schaich, M.
    Kroschinsky, F.
    Parmentier, S.
    Ehninger, G.
    Thiede, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 330 - 330
12345